Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Proper Use of the National Inpatient Sample Database to Analyze Safety of Cardiovascular Procedures.

Journal of the American Heart Association·2026

Same author

Complications of Catheter Ablation for Atrial Fibrillation in Patients with Rheumatic Diseases.

Journal of clinical medicine·2026

Same author

Integrative Clinical-Molecular Modeling Identifies <i>LRRN4CL</i> as a Determinant of Structural and Functional Myocardial Improvement.

bioRxiv : the preprint server for biology·2026

Same author

Compensating Heart Failure Cardiologists: Is the RVU Model the Right Model?

Circulation. Heart failure·2026

Same author

Financial Implications of GI Bleeding in Patients with LVAD: An Analysis from the US National Inpatient Sample Trends.

Medical sciences (Basel, Switzerland)·2026

Same author

Forgotten After Discharge? ECMO Patients Deserve Better.

Circulation. Heart failure·2025

Search research articles

Related Experiment Video

Updated: Jun 15, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Myocardial Recovery in Cardiogenic Shock.

Kevin John¹, Adnan Khalif², Masaki Tsukashita²

¹Tufts Medical Center, Boston, Massachusetts, US.

Methodist Debakey Cardiovascular Journal

|August 26, 2024

Summary

Improving cardiogenic shock (CS) outcomes focuses on preventing early death and promoting heart recovery. This review examines CS pathophysiology, recovery predictors, and knowledge gaps to enhance long-term survival strategies.

Keywords:

cardiogenic shock guideline-directed medical therapy mechanical circulatory support myocardial recovery

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 15, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

Cardiology
Critical Care Medicine
Pathophysiology

Background:

Cardiogenic shock (CS) presents significant challenges to long-term patient survival.
Current therapeutic strategies aim to reduce in-hospital mortality and prevent multiorgan failure.
Heart replacement therapies offer long-term survival but are limited to a select patient group.

Purpose of the Study:

To review the pathophysiology of the cardiogenic shock state.
To identify strategies for optimizing physiological factors to promote myocardial recovery.
To highlight current knowledge gaps and advocate for further research in CS myocardial recovery.

Main Methods:

Literature review focusing on cardiogenic shock pathophysiology.
Analysis of mechanisms to improve outcomes and promote heart recovery.
Examination of therapeutic targets and predictors of myocardial recovery.

Main Results:

Emphasis on addressing reversible etiologies contributing to the shock state.
Identification of key physiological factors critical for recovery.
Review of known predictors of myocardial recovery across various CS etiologies.

Conclusions:

Optimizing recovery from cardiogenic shock is crucial for long-term survival.
Further high-quality studies are needed to address knowledge gaps in myocardial recovery.
Targeting reversible causes and promoting recovery are key therapeutic goals.